Insider · CIK 0001339643

Nordlicht Mark

CIK 0001339643 Name as filed on the most recent filing

Filed as Nordlicht Mark (14)

30 transaction lines · from 14 filings · filed 2006-06-27 to 2014-09-04 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.

How this page attributes a trade

A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.

01

Issuers this insider has filed against

Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.

02

Transactions

Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.

8 transactions · Newest transaction date first, id breaking the tie.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-26 05:24 UTC.

Transactions filed by this insider
Direction Date Code Company Value USD Filing
2014-09-02 S, Open-market sale Navidea Biopharmaceuticals, Inc.NAVB 81,552, disposed Open Form 4 filing 0001140361-14-034864
2014-06-30 P, Open-market purchase Echo Therapeutics, Inc.ECTE 121,183, acquired Open Form 4 filing 0001140361-14-027289
2014-06-27 P, Open-market purchase Echo Therapeutics, Inc.ECTE 23,443, acquired Open Form 4 filing 0001140361-14-027289
2014-06-26 P, Open-market purchase Echo Therapeutics, Inc.ECTE 33,000, acquired Open Form 4 filing 0001140361-14-026909
2014-06-25 P, Open-market purchase Echo Therapeutics, Inc.ECTE 5,060, acquired Open Form 4 filing 0001140361-14-026909
2014-06-24 P, Open-market purchase Echo Therapeutics, Inc.ECTE 849, acquired Open Form 4 filing 0001140361-14-026587
2014-06-23 P, Open-market purchase Echo Therapeutics, Inc.ECTE 187, acquired Open Form 4 filing 0001140361-14-026587
2014-06-20 P, Open-market purchase Echo Therapeutics, Inc.ECTE 36,271, acquired Open Form 4 filing 0001140361-14-026587
2013-12-10 P, Open-market purchase Echo Therapeutics, Inc.ECTE 2 lines 191,315, acquired Open Form 4 filing 0001140361-13-045902
2009-09-25 S, Open-market sale Dais Analytic CorpDLYT.OB 1,211, disposed Open Form 4 filing 0001140361-09-024643
2009-09-24 S, Open-market sale Dais Analytic CorpDLYT.OB 14,905, disposed Open Form 4 filing 0001140361-09-024643
2009-09-23 S, Open-market sale Dais Analytic CorpDLYT.OB 106,037, disposed Open Form 4 filing 0001140361-09-024643
2009-09-22 S, Open-market sale Dais Analytic CorpDLYT.OB 8,755, disposed Open Form 4 filing 0001140361-09-024643
2009-09-16 S, Open-market sale Dais Analytic CorpDLYT.OB 2,040, disposed Open Form 4 filing 0001140361-09-024643
2009-08-07 S, Open-market sale NaturalNano , Inc.NNAN.OB 6,262, disposed Open Form 4 filing 0001263987-09-000007
2009-05-12 S, Open-market sale NaturalNano , Inc.NNAN.OB 950, disposed Open Form 4 filing 0001263987-09-000007
2009-05-11 S, Open-market sale NaturalNano , Inc.NNAN.OB 1,643, disposed Open Form 4 filing 0001263987-09-000007
2009-04-29 S, Open-market sale NaturalNano , Inc.NNAN.OB 7,485, disposed Open Form 4 filing 0001263987-09-000006
2009-04-29 S, Open-market sale NaturalNano , Inc.NNAN.OB 7,485, disposed Open Form 4 filing 0001263987-09-000003
2009-04-24 S, Open-market sale NaturalNano , Inc.NNAN.OB 3,000, disposed Open Form 4 filing 0001263987-09-000006
2009-04-24 S, Open-market sale NaturalNano , Inc.NNAN.OB 3,000, disposed Open Form 4 filing 0001263987-09-000003
2009-02-26 S, Open-market sale Optionable IncOPBL.OB 73,711, disposed Open Form 4 filing 0001144204-09-011168
2007-04-10 S, Open-market sale Optionable IncOPBL.OB 18,830,000, disposed Open Form 4 filing 0000932440-07-000287
2006-07-10 P, Open-market purchase Platinum Energy Resources IncPGRI 7,220, acquired Open Form 4 filing 0001144204-06-028278
2006-07-05 P, Open-market purchase Platinum Energy Resources IncPGRI 17,975, acquired Open Form 4 filing 0001144204-06-027431
2006-07-03 P, Open-market purchase Platinum Energy Resources IncPGRI 36,000, acquired Open Form 4 filing 0001144204-06-027431
2006-06-30 P, Open-market purchase Platinum Energy Resources IncPGRI 17,975, acquired Open Form 4 filing 0001144204-06-027431
2006-06-26 P, Open-market purchase Platinum Energy Resources IncPGRI 35,950, acquired Open Form 4 filing 0001144204-06-026422
2006-06-23 P, Open-market purchase Platinum Energy Resources IncPGRI 35,950, acquired Open Form 4 filing 0001144204-06-026422

This column is intentionally blank

No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.

Codes on this page
S, Open-market sale
Open-market sale
P, Open-market purchase
Open-market purchase
Relationships on this page
%, Ten percent owner
Ten percent owner
D, Director
Director

Every value is as reported on the Form 4, totalled to the dollar. Share counts, the price per share and the full list of reporting owners are on each filing's own page, which every row here opens. A row marked n lines adds up that many filed lines of one filing, on one day, on one side of the market; a filing whose lines fall across two pages is left as its lines on both, so no total here is ever short.

What this insider's stored lines contain

Exact counts over every stored line for this entity. This is a statement of composition, not a filter: the only filter this page offers is the open-market one above, because that is the only one an index serves today.

  • Open-market purchase 6
  • Open-market sale 2
  • Option exercise 0
  • Grant or award 0
  • Tax withholding 0
  • Disposition to the issuer 0
  • In-the-money option exercise 0

How to cite this page

ebomi catalog. Nordlicht Mark, insider transactions. Retrieved 2026-08-26 from https://ebomi.com/insider/0001339643

Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6

This page as JSON The JSON twin is shaped by the same read model as this page, so the two cannot disagree. Its envelope carries the canonical URL, the retrieval time, the coverage claim, and the licence statement.